Intra-Cellular Therapies Inc (ITCI)
68.82
-1.52
(-2.17%)
USD |
NASDAQ |
May 03, 16:00
68.82
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Shares Outstanding: 96.81M for Feb. 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 20, 2024 | 96.81M |
December 31, 2023 | 96.38M |
October 31, 2023 | 96.24M |
September 30, 2023 | 96.23M |
August 01, 2023 | 96.09M |
June 30, 2023 | 96.08M |
May 02, 2023 | 95.93M |
April 27, 2023 | 95.93M |
April 01, 2023 | 95.68M |
March 31, 2023 | 95.68M |
February 27, 2023 | 95.28M |
December 31, 2022 | 94.83M |
November 01, 2022 | 94.71M |
September 30, 2022 | 94.70M |
August 05, 2022 | 94.40M |
June 30, 2022 | 94.37M |
May 06, 2022 | 94.32M |
April 19, 2022 | 94.30M |
April 01, 2022 | 93.89M |
March 31, 2022 | 94.02M |
February 25, 2022 | 93.59M |
January 07, 2022 | 92.84M |
December 31, 2021 | 81.89M |
November 05, 2021 | 81.46M |
September 30, 2021 | 81.38M |
Date | Value |
---|---|
August 06, 2021 | 81.34M |
June 30, 2021 | 81.31M |
May 07, 2021 | 81.20M |
April 28, 2021 | 81.20M |
April 01, 2021 | 81.13M |
March 31, 2021 | 81.13M |
February 22, 2021 | 80.92M |
December 31, 2020 | 80.46M |
November 06, 2020 | 80.16M |
September 30, 2020 | 80.14M |
September 15, 2020 | 79.97M |
August 07, 2020 | 67.31M |
June 30, 2020 | 66.78M |
May 05, 2020 | 66.45M |
April 06, 2020 | 66.20M |
March 31, 2020 | 66.20M |
March 25, 2020 | 66.19M |
February 28, 2020 | 66.13M |
January 10, 2020 | 65.51M |
December 31, 2019 | 55.51M |
December 27, 2019 | 55.42M |
November 04, 2019 | 55.26M |
September 30, 2019 | 55.25M |
August 06, 2019 | 55.17M |
August 01, 2019 | 55.17M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
55.13M
Minimum
May 07 2019
96.81M
Maximum
Feb 20 2024
80.75M
Average
81.33M
Median
Shares Outstanding Benchmarks
Johnson & Johnson | 2.407B |
Insmed Inc | 148.49M |
Vertex Pharmaceuticals Inc | 258.31M |
Fate Therapeutics Inc | 99.24M |
ADMA Biologics Inc | 228.22M |